Evidence map›Paper›PMID 35011706›Full record

ArticleCells2022

New Therapy for Spinal Cord Injury: Autologous Genetically-Enriched Leucoconcentrate Integrated with Epidural Electrical Stimulation.

Rustem Islamov, Farid Bashirov, Andrei Izmailov, Filip Fadeev, Vage Markosyan, Mikhail Sokolov, Maksim Shmarov, Denis Logunov, Boris Naroditsky, Igor Lavrov

Open access · goldAbstract read
In one paragraph

Article in Cells, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 26 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Rustem IslamovDepartment of Medical biology and Genetics, Kazan State Medical University, 420012 Kazan, Russia.ORCID 0000-0002-6632-4636
Farid BashirovDepartment of Medical biology and Genetics, Kazan State Medical University, 420012 Kazan, Russia.
Andrei IzmailovDepartment of Medical biology and Genetics, Kazan State Medical University, 420012 Kazan, Russia.ORCID 0000-0002-8128-4636
Filip FadeevDepartment of Medical biology and Genetics, Kazan State Medical University, 420012 Kazan, Russia.ORCID 0000-0002-8119-3136
Vage MarkosyanDepartment of Medical biology and Genetics, Kazan State Medical University, 420012 Kazan, Russia.ORCID 0000-0002-3789-0284
Mikhail SokolovDepartment of Medical biology and Genetics, Kazan State Medical University, 420012 Kazan, Russia.ORCID 0000-0003-2938-6683
Maksim ShmarovThe National Research Center for Epidemiology and Microbiology Named after Honorary Academician N.F. Gamaleya of the Ministry of Health of the Russian Federation, 123098 Moscow, Russia.ORCID 0000-0002-5268-1296
Denis LogunovThe National Research Center for Epidemiology and Microbiology Named after Honorary Academician N.F. Gamaleya of the Ministry of Health of the Russian Federation, 123098 Moscow, Russia.
Boris NaroditskyThe National Research Center for Epidemiology and Microbiology Named after Honorary Academician N.F. Gamaleya of the Ministry of Health of the Russian Federation, 123098 Moscow, Russia.
Igor LavrovCenter for Neurobiology and Brain Restoration, Skolkovo Institute of Science and Technology, 121205 Moscow, Russia.ORCID 0000-0002-3885-4509
Kazan State Medical University · RUMinistry of Health of the Russian Federation · RUSkolkovo Institute of Science and Technology · RU

Funding

Russian Science Foundation 16-15-00010
6 · The paper itself

Abstract

The contemporary strategy for spinal cord injury (SCI) therapy aims to combine multiple approaches to control pathogenic mechanisms of neurodegeneration and stimulate neuroregeneration. In this study, a novel regenerative approach using an autologous leucoconcentrate enriched with transgenes encoding vascular endothelial growth factor (VEGF), glial cell line-derived neurotrophic factor (GDNF), and neural cell adhesion molecule (NCAM) combined with supra- and sub-lesional epidural electrical stimulation (EES) was tested on mini-pigs similar in morpho-physiological scale to humans. The complex analysis of the spinal cord recovery after a moderate contusion injury in treated mini-pigs compared to control animals revealed: better performance in behavioural and joint kinematics, restoration of electromyography characteristics, and improvement in selected immunohistology features related to cell survivability, synaptic protein expression, and glial reorganization above and below the injury. These results for the first time demonstrate the positive effect of intravenous infusion of autologous genetically-enriched leucoconcentrate producing recombinant molecules stimulating neuroregeneration combined with neuromodulation by translesional multisite EES on the restoration of the post-traumatic spinal cord in mini-pigs and suggest the high translational potential of this novel regenerative therapy for SCI patients.

Indexed as

AnimalsDisease Models, AnimalElectric StimulationEpidural SpaceFemaleGenetic TherapyLeukocyte CountSpinal Cord InjuriesSwineTransgenesautologous genetically-enriched leucoconcentratechimeric adenoviral vectorepidural electrical stimulationglial cell line-derived neurotrophic factormini-pigsneural cell adhesion moleculespinal cord contusion injuryvascular endothelial growth factor

Identifiers

PMID35011706
PMCPMC8750549
OpenAlexW4206826556

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.